BIONET Corp.

TPEX:1784 Stock Report

Market Cap: NT$4.1b

BIONET Past Earnings Performance

Past criteria checks 2/6

BIONET has been growing earnings at an average annual rate of 43.1%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 9.4% per year. BIONET's return on equity is 2.9%, and it has net margins of 4.7%.

Key information

43.1%

Earnings growth rate

43.3%

EPS growth rate

Healthcare Industry Growth9.1%
Revenue growth rate9.4%
Return on equity2.9%
Net Margin4.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Should You Investigate BIONET Corp. (GTSM:1784) At NT$43.50?

Apr 10
Should You Investigate BIONET Corp. (GTSM:1784) At NT$43.50?

If You Had Bought BIONET (GTSM:1784) Shares Three Years Ago You'd Have Earned 46% Returns

Feb 10
If You Had Bought BIONET (GTSM:1784) Shares Three Years Ago You'd Have Earned 46% Returns

Revenue & Expenses Breakdown

How BIONET makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TPEX:1784 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,17856465131
30 Jun 241,16363451132
31 Mar 241,16677446127
31 Dec 231,12778435119
30 Sep 231,10584426111
30 Jun 231,0628141396
31 Mar 231,0085739893
31 Dec 229803839590
30 Sep 229372539091
30 Jun 229181538094
31 Mar 229211938492
31 Dec 219212738686
30 Sep 219213538672
30 Jun 219043138861
31 Mar 218421937655
31 Dec 208071336352
30 Sep 20786635755
30 Jun 20763435254
31 Mar 20784336350
31 Dec 19776736747
30 Sep 197911437543
30 Jun 197851837742
31 Mar 197702337442
31 Dec 187712436643
30 Sep 187481835644
30 Jun 187411235243
31 Mar 18716533640
31 Dec 17697-633039
30 Sep 17673-1132037
30 Jun 17689-1131336
31 Mar 17689-1331837
31 Dec 16679-932238
30 Sep 16672-231739
30 Jun 16639532142
31 Mar 166431630645
31 Dec 156222329950
30 Sep 156181931452
30 Jun 156142431154
31 Mar 156183131754
31 Dec 146244431251
30 Sep 146364131049
30 Jun 146625330749
31 Mar 146674432946

Quality Earnings: 1784 has high quality earnings.

Growing Profit Margin: 1784's current net profit margins (4.7%) are lower than last year (7.6%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 1784's earnings have grown significantly by 43.1% per year over the past 5 years.

Accelerating Growth: 1784's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 1784 had negative earnings growth (-33.5%) over the past year, making it difficult to compare to the Healthcare industry average (7.3%).

Return on Equity

High ROE: 1784's Return on Equity (2.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 15:19
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BIONET Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiaowei HuangMasterlink Securities Corp.